Amneal Pharmaceuticals, Inc.
AMRX
$17.25
$0.201.17%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 4,562.61% | 1,035.91% | 161.65% | 103.20% | 101.93% |
| Total Depreciation and Amortization | -20.81% | -14.21% | -5.34% | 5.94% | 8.93% |
| Total Amortization of Deferred Charges | -41.47% | -32.97% | -22.91% | -5.24% | 34.09% |
| Total Other Non-Cash Items | 83.87% | 65.53% | 50.20% | 4.93% | -34.57% |
| Change in Net Operating Assets | -478.44% | -192.68% | -4,927.43% | -713.35% | -54.57% |
| Cash from Operations | -42.81% | -0.35% | 15.21% | 4.77% | 39.06% |
| Capital Expenditure | -46.72% | -53.07% | -63.81% | -57.32% | -78.10% |
| Sale of Property, Plant, and Equipment | -48.15% | 199.62% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | 40.41% | 40.41% |
| Other Investing Activities | -925.96% | -109.44% | -5.90% | 61.37% | 70.33% |
| Cash from Investing | -161.81% | -90.34% | -78.21% | -5.39% | -13.62% |
| Total Debt Issued | 1,246.69% | 1,201.06% | 5,981.49% | 678.78% | -43.34% |
| Total Debt Repaid | -587.48% | -570.37% | -1,106.05% | -549.98% | 5.53% |
| Issuance of Common Stock | -15.51% | 61.42% | 69.84% | 48.95% | 81.84% |
| Repurchase of Common Stock | -100.50% | -100.83% | -180.16% | -189.39% | -190.42% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -205.23% | -560.92% | -497.84% | 33.51% | 81.76% |
| Cash from Financing | 129.70% | 77.43% | 85.11% | 67.14% | 4.58% |
| Foreign Exchange rate Adjustments | -38.41% | -71.24% | -68.17% | -3,712.07% | -312.57% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 64.31% | 710.72% | 907.19% | 1,027.25% | 152.42% |